Tales of Tamar

Economic implications of widespread Ivermectin use, including the branded ivermectin use, extend beyond direct healthcare costs. Its impact on public health systems, insurance coverage, and patient out-of-pocket expenses underscores the multifaceted nature of drug accessibility and affordability. Discussions about Ivermectin often lead to broader debates on pharmaceutical pricing, patent laws, and the balance between innovation and access.